Stay updated on Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    Change Detected
    Summary
    The study page now shows a 403 Forbidden error, replacing the previous study details and related metadata with an access-denied message. As a result, the clinical trial record is no longer viewable on the page.
    Difference
    18%
    Check dated 2026-09-20T22:41:54.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    A new page revision tag v3.6.6 was added and the previous v3.6.5 revision was removed. This indicates the page has been updated to a newer version.
    Difference
    0.1%
    Check dated 2026-08-30T22:23:24.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    The page's revision marker was updated from v3.6.4 to v3.6.5, indicating a minor update to the page's documentation or version history.
    Difference
    0.1%
    Check dated 2026-08-09T11:33:42.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Revision updated from v3.6.3 to v3.6.4 to reflect a newer version of the page/template. This is a metadata change and does not alter the study details or user-facing content.
    Difference
    0.1%
    Check dated 2026-07-25T23:30:41.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    A new endpoint, ‘Cumulative Percentage of Patients Remaining Distant Metastases-Free/Alive at 1yr and 2yrs After Initial Treatment,’ was added on 2026-07-16, and the previous endpoint ‘Percentage of Participants With Distant Metastases-free Survival’ was removed on 2026-06-16, reflecting a refinement of the distant metastases–free survival measure.
    Difference
    0.3%
    Check dated 2026-07-18T20:26:10.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    The page's revision tag was updated to version v3.6.3, representing a small update to the page's template or backend tracking rather than any substantive change to the study details.
    Difference
    0.1%
    Check dated 2026-07-04T13:29:55.000Z thumbnail image

Stay in the know with updates to Nivolumab for Stage IIB-IIC Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab for Stage IIB-IIC Melanoma Clinical Trial page.